tradingkey.logo
搜索

Caris Life Sciences Inc

CAI
添加自选
29.980USD
-0.940-3.04%
收盘 09-18 16:00美东
8.47B总市值
亏损市盈率 TTM
盘后交易 16:12 (美东)29.810USD-0.135-0.45%

关于 Caris Life Sciences Inc 公司

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Inc 简介

公司代码CAI
公司名称Caris Life Sciences Inc
上市日期Jun 18, 2025
CEOHalbert (David Dean)
员工数量- -
证券类型Ordinary Share
年结日Jun 18
公司地址750 W. John Carpenter Freeway
城市IRVING
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编75039
电话18667718946
网址https://www.carislifesciences.com/
公司代码CAI
上市日期Jun 18, 2025
CEOHalbert (David Dean)

Caris Life Sciences Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
513.30K
+0.31%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Luke Power, CPA
Mr. Luke Power, CPA
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
Independent Director
Independent Director
--
--
Mr. Jon S. Halbert
Mr. Jon S. Halbert
Director
Director
--
--
Ms. Laura I. Johansen
Ms. Laura I. Johansen
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
513.30K
+0.31%
Mr. David Dean Halbert
Mr. David Dean Halbert
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Brian J. Brille
Mr. Brian J. Brille
Vice Chairman of the Board, Executive Vice President
Vice Chairman of the Board, Executive Vice President
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Mr. Luke Power, CPA
Mr. Luke Power, CPA
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--

常见问题

Caris Life Sciences Inc的前五大股东是谁?

Caris Life Sciences Inc 的前五大股东如下:Dr. George H. Poste, Ph.D.
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有